Learn about the latest advances in lung disease treatment from the experts of the Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine, led by Charles A. Powell, MD, the Janice and Coleman Rabin Professor of Medicine. Our physicians offer the latest treatment options for conditions such as asthma, sleep apnea, cystic fibrosis, interstitial lung disease, lung cancer and bronchiectasis, emphysema, chronic pulmonary obstructive disease (COPD), and more. For patients with sarcoidosis, we offer one of the largest programs in the nation, providing the latest treatment options. Our integrated sleep center is conducting groundbreaking research through important collaborations with our partners in cardiology, genomics, and clinical immunology, and our lung cancer and lung transplant programs are leading the nation in discoveries of new treatments and development of new procedures.
Through our affiliation with National Jewish Health—a leading respiratory hospital in the country—we have established the Mount Sinai-National Jewish Health Respiratory Institute to provide comprehensive patient care and conduct research that has a real and lasting effect on our patients today, and into the future. Our intensivists have been on the front lines of the COVID-19 pandemic, and have pioneered a number of innovative therapeutic techniques and medications that have saved countless lives.
Referring a patient is easy. Just click the “Refer a Patient Online” button.
Learn about the latest advances in lung disease treatment from the experts of the Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine, led by Charles A. Powell, MD, the Janice and Coleman Rabin Professor of Medicine. Our physicians offer the latest treatment options for conditions such as asthma, sleep apnea, cystic fibrosis, interstitial lung disease, lung cancer and bronchiectasis, emphysema, chronic pulmonary obstructive disease (COPD), and more. For patients with sarcoidosis, we offer one of the largest programs in the nation, providing the latest treatment options. Our integrated sleep center is conducting groundbreaking research through important collaborations with our partners in cardiology, genomics, and clinical immunology, and our lung cancer and lung transplant programs are leading the nation in discoveries of new treatments and development of new procedures.
Through our affiliation with National Jewish Health—a leading respiratory hospital in the country—we have established the Mount Sinai-National Jewish Health Respiratory Institute to provide comprehensive patient care and conduct research that has a real and lasting effect on our patients today, and into the future. Our intensivists have been on the front lines of the COVID-19 pandemic, and have pioneered a number of innovative therapeutic techniques and medications that have saved countless lives.
Referring a patient is easy. Just click the “Refer a Patient Online” button.
Latest Content
Pulmonology, Critical Care and Sleep Medicine Specialty Report 2022
From addressing the aftermath of COVID-19 to stepping up the fight against lung cancer, Mount Sinai’s Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine continues to move the field forward.
Disparities and Health: Through the Lens of Household Air Pollution Exposure
Air pollution in the home: Who's at risk?
EATI: East Africa Training Initiative; Lessons Learned from Teaching in a Resource-Poor Setting
Teaching in Africa: Lessons learned in a remote location
Three Prestigious Institutions Band Together Against Common Challenges
Mount Sinai Health System, Jefferson Health, and National Jewish Health have begun working together to advance understanding, diagnosis, and treatment of a range of pulmonary diseases, some of which have traditionally been orphan diseases.
Working Toward Anti-Racism in Training and Care Programs
The Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine, like the entire Mount Sinai Health System, is making concerted efforts to become an anti-racist institution.
Providing High-Level Care to Infants and Children With Chronic Respiratory Conditions
The multidisciplinary Chronic Lung Care Program at Mount Sinai Kravis Children’s Hospital was established to help care for infants in the NICU with evolving and established chronic respiratory failure.
Gene Signatures May Predict Outcomes Among Similar-Appearing Tumors
Gene signatures derived from lung carcinoma could potentially predict outcomes among individuals with small lung cancers detected by chest CT imaging, when those tumors cannot be distinguished visually as aggressive or indolent.
Building a Hub to Catch Lung Cancer Early
Fewer than 10 percent of potentially eligible patients undergo lung cancer screening, resulting in unnecessary illness and death. The new Chief of Pulmonary, Critical Care and Sleep Medicine at Mount Sinai Morningside wants to change that.
Decline in Lung Cancer Deaths Is Linked to Increased Screening
A recent, substantial decline in lung cancer deaths is associated with earlier diagnosis of lung cancer than in the past, a new study shows.
Nationwide Study of 'Long COVID' Will Put Lungs Front and Center
Mount Sinai will serve as a hub site for two cohort studies as part of the NIH Researching COVID to Enhance Recovery (RECOVER) Initiative, which will assess the post-acute sequelae of SARS-CoV-2 infection (PASC).
Driven by COVID-19 Sequelae, Mount Sinai Establishes Lung Transplant Program
Mount Sinai Health System has recruited two world-renowned experts to establish a lung transplantation program that will care for both traditional and highly complex cases. The demand for these services is projected to grow as more patients ...
Moving Ahead: From COVID-19 to Lung Cancer Screening
From addressing the aftermath of COVID-19 to stepping up the fight against lung cancer, Mount Sinai’s Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine continues to move the field forward.
Collaborative Airway Institute Established at Mount Sinai
Like-minded scientists and physician-scientists will collaborate with pulmonologists, otolaryngologists, head and neck oncologists, and transplant surgeons to collaborate on research related to the airway within the Institute for Airway ...
Anti-HER2 Treatments Can Cause Pulmonary Toxicities in HER2+ Breast Cancer
Charles Powell, MD, System Chief for Pulmonary, Critical Care and Sleep Medicine at the Icahn School of Medicine and CEO of the Mount Sinai-National Jewish Health Respiratory Institute, answers questions regarding anti-HER2 monoclonal ...
Pulmonology, Critical Care and Sleep Medicine Specialty Report 2021
Even before the first patient arrived at our doors, a Mount Sinai research team working with CT scans from patients in China noticed that this disease did not look like a normal pneumonia.